Acute Myocardial Infarction as an Initial Symptom of Streptococcus suis Infection: A Case Report

Abstract

Streptococcus suis (S. suis) infection, a zoonotic infection with a global distribution, is clinically manifested by meningitis, followed by sepsis, infective endocarditis and arthritis. S. suis infection is not uncommon, but acute myocardial infarction (AMI), as an initial symptom, has not yet been reported. We report a case of S. suis infection with AMI as an initial symptom. The patient, a previously healthy butcher with no known risk factors for AMI, was admitted to hospital with a sudden onset of AMI. Then, thrombolytic therapy, anticoagulation therapy with nadroparin calcium and antiplatelet therapy with aspirin and ticagrelor were adopted. Two days later, blood cultures in aerobic and anaerobic bottles were positive for S. suis and he received antibiotic therapy with piperacillin/tazobactam. Then, his symptoms improved and he was transferred to a special infectious disease hospital for further treatment and was discharged upon complete recovery. To the best of our knowledge, this is the first reported case of AMI as the initial symptom of S. suis infection, which illustrates a possible new symptom of this important pathogen. For AMI patients with unexplained infections, and who are in close frequent contact with pigs and/or pork products, clinicians should be alert to the possibility of S. suis infections.

Keywords:

• Streptococcus suis
• acute myocardial infarction
• sepsis
• zoonosis

Introduction

Streptococcus suis (S. suis) is a zoonotic pathogen that is transmitted to humans through close contact with infected pigs and/or pork products, which was first reported by Arends and Zanen in Denmark in 1988.¹ The exact route and mechanism of S. suis infection in humans has not been established. Possible transmission routes include inoculation on skin wounds, bioaerosol inhalation and contaminated pork ingestion.²⁻⁴

S. suis is a facultatively anaerobic Gram-positive cocci that causes meningitis, sepsis, infective endocarditis and arthritis. There exists significant variation in the symptom of S. suis infection. Common signs and symptoms include high fever, chills, headache, vomiting, vertigo and rashes. But additionally, hearing loss, walking ataxia, rhabdo myolysis and coma can be observed in patients with meningitis. In patients with toxic septic shock, we can observe hypotension, tachycardia and disseminated intravascular coagulation (DIC).⁴

Previous studies have shown that gram-negative community-acquired bacteremia (CAB) and gram-positive CAB were correlated with risk of AMI. Among them, Streptococcus pneumoniae and Staphylococcus aureus are the representative gram-positive cocci, as was Escherichia coli for the gram-negative cocci.⁵ Globally, over 1600 cases of S. suis infections have been reported. However, no acute myocardial infarction (AMI) associated with S. suis infection has been reported. We report a case of S. suis infection-induced AMI, and illustrate a possible new symptom of this important pathogen.

The patient provided informed consent to publish their case details and any accompanying images.

Case Presentation

A previously healthy 49-year-old male who had been a butcher for 10 years, often injured and wounded his hands at work. He was admitted at a local hospital with a 10-hour acute chest pain that was accompanied by sweating, bilateral lower extremity muscle soreness and limited movements. Upon examination, electrocardiogram (ECG) analysis revealed AMI, as well as hypotension with a blood pressure of 75/36 mmHg. Then, he was administered with thrombolysis therapy. Due to unsatisfactory therapeutic effect, he was referred to our hospital.

Physical examination upon admission: body temperature 37.4 °C; a heart rate of 108 beats/min, a respiratory rate of 32 breaths/min while his blood pressure was 96/67 mmHg. Red rash that was fadable by pressing was seen on the shin over the neck and on the upper chest. Heart murmurs were not detected on auscultation and muscle strength testing revealed extremity muscles strength grade 3. The left little finger of the patient exhibited a cutting wound that was attributed to slaughtering pigs 5 days ago. ECG analysis revealed mild ST-segment elevation and abnormal Q waves in III and aVF; sinus tachycardia and complete right bundle branch block (Figure 1). Transthoracic echocardiography (TTE) analyses revealed suppressed motion amplitude in the basal segments of inferior wall and apical segments without any obvious sign of valve vegetation. Pulmonary computed tomographic angiography (CTA) showed bilateral pleural effusion and inflammation (Figure 2). Laboratory analysis showed an increased white blood cell (WBC) count (44.84 × 10^9 cells/L) with 95.8% neutrophils, procalcitonin (PCT) at 32 ng/mL, C-reactive protein (CRP) at 170 mg/L, serum creatinine levels of 176.7 umol/L, lactic acid at 3.4 mmol/L, cardiac troponin I (cTnI) level of 24.05 ng/mL, creatine kinase MB (CK-MB) level of 40.3 ng/mL and myoglobin (MYO) at 118.9 ng/mL, while peripheral blood morphology examination revealed that the abundance of middle and late granulocytes were 3%. On this study, the primary diagnosis was AMI and sepsis. Changes in hemodynamic parameters, temperature, inflammatory and myocardial injury markers during hospitalization are shown in Figures 3–5, respectively.

Figure 1 Electrocardiograph analysis showed mild ST-segment elevation and abnormal Q waves in III and aVF; sinus tachycardia and complete right bundle branch block.

Figure 2 Pulmonary computed tomographic angiography (CTA) showed bilateral pleural effusion and inflammation (pulmonary window and mediastinal window).

Figure 3 Changes in temperature and blood pressures during hospitalization.

Figure 4 Changes in inflammatory markers during hospitalization.

Figure 5 Changes in myocardial injury markers during hospitalization.

The patient was quickly admitted to the department of cardiac intensive medicine. Aspirin and ticagrelor were administered in combination with antiplatelet aggregation, nadroparin calcium anticoagulant, rehydration, and papaverine hydrochloride, which improved coronary blood flow. In consideration of unidentified infections, he was instantly empirically intravenously administered with piperacillin/tazobactam (4.5 g, every 8 h). A day later, his blood pressure had returned to 104/64 mmHg, but his body temperature fluctuated between 37 and 38 °C. Forty-eight hours later, blood cultures in aerobic and anaerobic bottles were positive for S. suis. Unfortunately, S. suis was not identified at the serotype level due to limited assay conditions. Antimicrobial susceptibility testing revealed sensitivity to ceftriaxone, ampicillin, penicillin, linezolid and levofloxacin, as well as resistance to erythromycin and clindamycin. Based on these findings, we continued with the anti-infection regimen. On day 3 after admission, cTnI, CK-MB and MYO levels decreased to 4.760 ng/mL, 8.80 ng/mL and 45.40 ng/mL, respectively, his body temperature decreased to 36.8 °C and his haemodynamics stabilized. After communicating with family members, he was transferred to a special infectious disease hospital for further treatment on day 4. His WBC count had decreased to 11.79 × 10^9 cells/L with 71.6% neutrophils when he was transferred to the special infectious disease hospital.

Discussion

This is a case of middle-aged male with no known risk factors for cardiovascular disorders, presenting with AMI as an initial symptom of S. suis infection. In our management the initial priority was to sustain the hemodynamics stable. We also noted that the patient with unidentified infections, he was given antibiotics. The diagnosis of S. suis infection was not made until obtained positive blood culture results.

S. suis is a zoonotic pathogen that is transmitted from infected pigs to humans by close contact. Based on their capsular polysaccharides, S. suis can be classified into 35 serotypes, of which serotype 2 is the most common serotype in human beings worldwide, followed by serotype 14.^4,6 S. suis serotype is important in epidemiological studies, to understand the genetic diversity and evolution of capsular polysaccharides in S. suis.⁷ Initially, microbial identification of S. suis was done by using biochemical tests.⁸ But because biochemical test results for different types of S. suis is significantly varied, other test methods are necessary to type accurately.⁹ With the development of molecular biology technology, polymerase chain reaction (PCR) technology is playing an increasingly essential role in S. suis detection. Neither general PCR nor multiplex PCR (m-PCR) could differentiate certain serotypes.⁹ Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) has proven to be a reliable identification tool for microbial identification, including S. suis identification.⁸ This coupled with PCR technology could improve awareness of the epidemiology and virology of S. suis. Unfortunately, we were able to identify S. suis by conventional bacterial culture method only due to the lack of corresponding experience and laboratory equipment. If serotype had been identified, I believe that it would have been more epidemiological implications.

Meningitis is the most common clinical manifestation of S. suis infection, followed by sepsis, infective endocarditis and arthritis.¹⁰ Although S. suis can cause infective endocarditis, no AMI associated with infection has been found so far for S. suis.

Acute infection and AMI are both leading causes of short-term mortality worldwide.¹¹ Previous studies have demonstrated that acute infection may be an acute trigger for cardiovascular events. It commonly involved in AMI include preceding urinary tract and respiratory infections as well as sepsis.¹² Potential mechanisms of acute infection-induced AMI include demand ischemia, decreasing myocardial contractility and coagulation disturbance.⁵

The majority cases with post-infectious AMI are type 2 MI, which was characterized by insufficient oxygen supply.¹³ Zhang et al¹⁴ found that there is an important interplay between the S. suis suilysin and human platelet, which plays a major role in the process of human platelet activation and aggregation. The process is completed triggered by pore dependent Ca²⁺ influx, which is fundamental to thrombosis. In our case, the patient had been a butcher by profession for 10 years, and his left little finger had developed a wound 5 days prior to hospital admission. We believe that his severe S. suis infection was due to this wound. His chest pain symptoms appeared after finger injury, and he had no known predisposing risk factors for AMI. Combined with the results of previously relevant research and his clinical condition, AMI was therefore considered to have been caused by S. suis infections. But in doing so, we do not have any direct evidence proved that AMI was induced by S. suis infection. Of course, whether AMI as a new symptom of this important pathogen needs to be further studied.

S. suis is sensitive to many antibiotics. For patients with confirmative S. suis infections, antibiotic treatment should be immediately administered. Currently, penicillin G is recommended as first choice therapeutic option for S. suis infection.⁴ Combinations of penicillin G with one or more other antibiotics, including ampicillin and ceftriaxone are considered for severely infected patients.^4,15 These results were consistent with those of our antimicrobial susceptibility tests. Restoring coronary blood flow, through percutaneous coronary intervention (PCI), is the gold standard for management of conventional acute myocardial infarction (AMI). Based on date from the American National Inpatient Sample database, revascularization was associated with half-reduced in-hospital mortality.¹⁶ Different points of view also existed in some studies. Putot et al concluded that percutaneous coronary intervention (PCI) might not improve short- and long-term prognosis in patients with significant coronary stenosis.¹⁷ But in any case, revascularization may be beneficial for patients who are in medical emergencies. Meanwhile, anti-infection treatment must be used as early as possible. Therefore, we gave anticoagulant treatment along with anti-infection therapy, which led to favorable outcomes.

Despite combinations of antibiotics and other associated treatments, there are some sequelae. Hearing loss, which occurs in 53% of S. suis infected individuals is the most clinical sequelae. It is followed by vestibular dysfunction, ataxia and cognitive impairment.¹⁸ However, compared to patients without STSS, STSS patients are associated with higher mortality rates, despite adequate treatments.^4,19 Fortunately, the patient was treated for infection-induced AMI without delay, and he was without sequelae after 3 months of follow-up.

Conclusions

In summary, S. suis is a significant zoonotic pathogen that is associated with severe life-threatening complications. We describe the first case of AMI as the initial symptom of S. suis infection. Systematic education on S. suis is the most cost-effective and easiest method for improving the recognition and awareness of this disorder in both patients and physicians. For people in close frequent contact with pigs and/or pork products, the presence of AMI combined with unexplained infections should be taken as possibility of S. suis infection. In concurrent AMI treatment, a timely and appropriate empirical antibiotic therapeutic regimen is pivotal to avoid continuous damage.

Abbreviations

S. suis, Streptococcus suis; AMI, Acute myocardial infarction; ECG, Electrocardiogram; TTE, Transthoracic echocardiography; CT, Computed tomography; WBC, White blood cell; PCT, Procalcitonin; CRP, C-reactive protein; cTnI, Cardiac troponin I; CK-MB, Creatine kinase MB; MYO, Myoglobin; STSS, Streptococcal toxic shock syndrome.

Ethics Approval and Consent to Participate

Ethics approval for this case report has been provided by the ethics committee of Affiliated Hospital of Jining Medical University.

Author Contributions

All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; took part in drafting the article or revising it critically for important intellectual content; agreed on the journal to which the article will be submitted; gave final approval of the version to be published; and agreed to be accountable for all aspects of the work.

Acknowledgments

We appreciate the patient and medical staff members’ cooperation in this case report.

Disclosure

The authors declare that they have no competing interests.

Additional information

Funding

This work was supported by Medicine and Health Technology Development Plan Project of Shandong Province (2016WSB34060 to XML), Teacher-Supporting Science Foundation of Jining Medical University (JYFC2018FKJ170 to XML), Key Research and Development Program of Jining Science and Technology Bureau (2020JKNS007 to XML) and Natural Science Foundation of Shandong Province (ZR202102280514 to HSL).